Exane Derivatives’s H&R Block HRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-29
Closed -$725 920
2021
Q3
$725 Hold
29
﹤0.01% 899
2021
Q2
$685 Buy
+29
New +$687 ﹤0.01% 913
2021
Q1
Sell
-29
Closed -$460 950
2020
Q4
$460 Hold
29
﹤0.01% 747
2020
Q3
$472 Hold
29
﹤0.01% 681
2020
Q2
$414 Sell
29
-104
-78% -$1.64K ﹤0.01% 624
2020
Q1
$1.87K Hold
133
﹤0.01% 503
2019
Q4
$3.26K Sell
133
-135,021
-100% -$3.24M ﹤0.01% 461
2019
Q3
$3.19M Buy
135,154
+135,109
+300,242% +$3.58M 0.57% 51
2019
Q2
$1.32K Buy
+45
New +$1.21K ﹤0.01% 542
2019
Q1
Sell
-129,918
Closed -$3.29M 694
2018
Q4
$3.29M Buy
129,918
+11,442
+10% +$305K 0.59% 45
2018
Q3
$3.05M Buy
118,476
+118,470
+1,974,500% +$3.01M 0.57% 50
2018
Q2
$137 Sell
6
-89,278
-100% -$2.37M ﹤0.01% 599
2018
Q1
$2.24M Buy
89,284
+60,122
+206% +$1.58M 0.45% 48
2017
Q4
$764K Buy
29,162
+25,614
+722% +$665K 0.13% 131
2017
Q3
$93.9K Sell
3,548
-76,775
-96% -$2.23M 0.02% 270
2017
Q2
$2.48M Buy
+80,323
New +$2.11M 0.53% 41

Other funds holding HRB

Exane Derivatives's HRB Position: Q4 2021 in Review

Exane Derivatives sold out of H&R Block (HRB) in Q4 2021, closing a stake of 29 shares — an estimated $725 sold.

Exane Derivatives first reported a position in HRB in Q2 2017 and held it in 16 quarters. The position peaked at $3.29M in Q4 2018. 387 funds tracked by Wall St. Rank hold HRB as of Q4 2021.

  • Exane Derivatives reported no remaining H&R Block position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 29 H&R Block shares in Q4 2021, an estimated $725.
  • Exane Derivatives first reported a position in H&R Block in Q2 2017 and held it in 16 quarters.
  • Exane Derivatives's H&R Block position peaked at $3.29M in Q4 2018.
  • 387 funds tracked by Wall St. Rank held H&R Block as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.